Labeler
Gilead Sciences, Inc. NDC Codes
Gilead Sciences, Inc. lists 50 finished drug products in the FDA NDC Directory under NDC labeler codes 55135, 61958.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Viread, Epclusa, Harvoni, Sovaldi, Truvada, Sunlenca, Biktarvy, Yeztugo, Descovy, Zydelig, Letairis, Emtriva, Bixlenvo, Hepcludex, Livdelzi
- Active ingredients
- Emtricitabine, Sofosbuvir, Tenofovir disoproxil fumarate, Tenofovir alafenamide fumarate, Velpatasvir, Bictegravir sodium, Ledipasvir, Lenacapavir sodium, Cobicistat, Rilpivirine hydrochloride, Elvitegravir, Idelalisib
- NDC labeler codes
- 55135, 61958
- Strengths
- Emtricitabine 200 mg/1; Sofosbuvir 200 mg/1; Tenofovir alafenamide fumarate 25 mg/1; Sofosbuvir 400 mg/1; Tenofovir disoproxil fumarate 300 mg/1; Emtricitabine 120 mg/1; Tenofovir alafenamide fumarate 15 mg/1; Sofosbuvir 150 mg/1; Cobicistat 150 mg/1; Lenacapavir sodium 300 mg/1; Bictegravir sodium 30 mg/1; Velpatasvir 50 mg/1; Ledipasvir 45 mg/1; Velpatasvir 100 mg/1; Tenofovir disoproxil fumarate 150 mg/1; Tenofovir disoproxil fumarate 200 mg/1; Tenofovir disoproxil fumarate 250 mg/1; Rilpivirine hydrochloride 25 mg/1; Elvitegravir 150 mg/1; Bictegravir sodium 75 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Pellet, Kit, Tablet, Coated, Injection, Powder, Lyophilized, For solution, Capsule, Powder, For solution, Powder, Solution
- Routes
- Oral, Intravenous, Subcutaneous
- Drug classes (FDA established)
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor, Hepatitis C Virus NS5A Inhibitor, Human Immunodeficiency Virus 1 Capsid Inhibitor, Cytochrome P450 3A Inhibitor, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Kinase Inhibitor, Endothelin Receptor Antagonist, SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor, Hepatitis C Virus NS3/4A Protease Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 65
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Bixlenvobictegravir/lenacapavir | Bictegravir sodium 75 mg/1; Lenacapavir sodium 50 mg/1 | Tablet, Film coatedOral | 61958-3601 | 61958-3601-01 | — |
| Hepcludexbulevirtide | Bulevirtide acetate 8.5 mg/1 | Injection, Powder, Lyophilized, For solutionSubcutaneous | 61958-3104 | 61958-3104-01 | — |
| Yeztugolenacapavir sodium | Lenacapavir sodium 300 mg/1 | Tablet, Film coatedOral | 61958-3401 | 61958-3401-01 | — |
| Yeztugolenacapavir sodium | — | Kit | 61958-3402 | 61958-3402-01 | — |
| Sunlencalenacapavir sodium | — | Kit | 61958-3005 | 61958-3005-01 | — |
| Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate | Bictegravir sodium 30 mg/1 + 2 more ingredients | TabletOral | 61958-2506 | 61958-2506-01 | — |
| Livdelziseladelpar lysine | Seladelpar lysine 10 mg/1 | CapsuleOral | 61958-3301 | 61958-3301-0161958-3301-02 | — |
| Sunlencalenacapavir sodium | Lenacapavir sodium 300 mg/1 | Tablet, Film coatedOral | 61958-3001 | 61958-3001-0161958-3001-0261958-3001-03 | — |
| Sunlencalenacapavir sodium | — | Kit | 61958-3002 | 61958-3002-01 | — |
| Descovyemtricitabine and tenofovir alafenamide | Emtricitabine 120 mg/1; Tenofovir alafenamide fumarate 15 mg/1 | TabletOral | 61958-2005 | 61958-2005-01 | — |
| Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate | Bictegravir sodium 30 mg/1 + 2 more ingredients | TabletOral | 61958-2505 | 61958-2505-01 | — |
| Epclusavelpatasvir and sofosbuvir | Velpatasvir 50 mg/1; Sofosbuvir 200 mg/1 | PelletOral | 61958-2204 | 61958-2204-01 | — |
| Epclusavelpatasvir and sofosbuvir | Velpatasvir 37.5 mg/1; Sofosbuvir 150 mg/1 | PelletOral | 61958-2205 | 61958-2205-01 | — |
| Vekluryremdesivir | Remdesivir 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 61958-2901 | 61958-2901-02 | — |
| Trodelvysacituzumab govitecan | Sacituzumab govitecan 180 mg/1 | Powder, For solutionIntravenous | 55135-132 | 55135-0132-01 | — |
| Epclusavelpatasvir and sofosbuvir | Velpatasvir 50 mg/1; Sofosbuvir 200 mg/1 | Tablet, Film coatedOral | 61958-2203 | 61958-2203-01 | — |
| Harvoniledipasvir and sofosbuvir | Ledipasvir 33.75 mg/1; Sofosbuvir 150 mg/1 | PelletOral | 61958-1805 | 61958-1805-01 | — |
| Harvoniledipasvir and sofosbuvir | Ledipasvir 45 mg/1; Sofosbuvir 200 mg/1 | Tablet, Film coatedOral | 61958-1803 | 61958-1803-01 | — |
| Harvoniledipasvir and sofosbuvir | Ledipasvir 45 mg/1; Sofosbuvir 200 mg/1 | PelletOral | 61958-1804 | 61958-1804-01 | — |
| Sovaldisofosbuvir | Sofosbuvir 150 mg/1 | PelletOral | 61958-1504 | 61958-1504-01 | — |
| Sovaldisofosbuvir | Sofosbuvir 200 mg/1 | Tablet, Film coatedOral | 61958-1503 | 61958-1503-01 | — |
| Sovaldisofosbuvir | Sofosbuvir 200 mg/1 | PelletOral | 61958-1505 | 61958-1505-01 | — |
| Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate | Bictegravir sodium 50 mg/1 + 2 more ingredients | TabletOral | 61958-2501 | 61958-2501-0161958-2501-0261958-2501-03+1 more | — |
| Vosevisofosbuvir, velpatasvir, and voxilaprevir | Sofosbuvir 400 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 61958-2401 | 61958-2401-01 | — |
| Vemlidytenofovir alafenamide | Tenofovir alafenamide fumarate 25 mg/1 | TabletOral | 61958-2301 | 61958-2301-01 | — |
| Epclusavelpatasvir and sofosbuvir | Velpatasvir 100 mg/1; Sofosbuvir 400 mg/1 | Tablet, Film coatedOral | 61958-2201 | 61958-2201-01 | — |
| Descovyemtricitabine and tenofovir alafenamide | Emtricitabine 200 mg/1; Tenofovir alafenamide fumarate 25 mg/1 | TabletOral | 61958-2002 | 61958-2002-0161958-2002-02 | — |
| Truvadaemtricitabine and tenofovir disoproxil fumarate | Emtricitabine 100 mg/1; Tenofovir disoproxil fumarate 150 mg/1 | Tablet, Film coatedOral | 61958-0703 | 61958-0703-01 | — |
| Truvadaemtricitabine and tenofovir disoproxil fumarate | Emtricitabine 133 mg/1; Tenofovir disoproxil fumarate 200 mg/1 | Tablet, Film coatedOral | 61958-0704 | 61958-0704-01 | — |
| Truvadaemtricitabine and tenofovir disoproxil fumarate | Emtricitabine 167 mg/1; Tenofovir disoproxil fumarate 250 mg/1 | Tablet, Film coatedOral | 61958-0705 | 61958-0705-01 | — |
| Odefseyemtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide | Emtricitabine 200 mg/1 + 2 more ingredients | TabletOral | 61958-2101 | 61958-2101-01 | — |
| Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide | Elvitegravir 150 mg/1 + 3 more ingredients | TabletOral | 61958-1901 | 61958-1901-01 | — |
| Harvoniledipasvir and sofosbuvir | Ledipasvir 90 mg/1; Sofosbuvir 400 mg/1 | Tablet, Film coatedOral | 61958-1801 | 61958-1801-01 | — |
| Tybostcobicistat | Cobicistat 150 mg/1 | Tablet, Film coatedOral | 61958-1401 | 61958-1401-01 | — |
| Zydeligidelalisib | Idelalisib 150 mg/1 | Tablet, Film coatedOral | 61958-1702 | 61958-1702-01 | — |
| Zydeligidelalisib | Idelalisib 100 mg/1 | Tablet, Film coatedOral | 61958-1701 | 61958-1701-01 | — |
| Sovaldisofosbuvir | Sofosbuvir 400 mg/1 | Tablet, Film coatedOral | 61958-1501 | 61958-1501-01 | — |
| Stribildelvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | Elvitegravir 150 mg/1 + 3 more ingredients | Tablet, Film coatedOral | 61958-1201 | 61958-1201-01 | — |
| Vireadtenofovir disoproxil fumarate | Tenofovir disoproxil fumarate 40 mg/g | PowderOral | 61958-0403 | 61958-0403-01 | — |
| Vireadtenofovir disoproxil fumarate | Tenofovir disoproxil fumarate 250 mg/1 | Tablet, CoatedOral | 61958-0406 | 61958-0406-01 | — |
| Vireadtenofovir disoproxil fumarate | Tenofovir disoproxil fumarate 150 mg/1 | Tablet, CoatedOral | 61958-0404 | 61958-0404-01 | — |
| Vireadtenofovir disoproxil fumarate | Tenofovir disoproxil fumarate 200 mg/1 | Tablet, CoatedOral | 61958-0405 | 61958-0405-01 | — |
| Compleraemtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate | Emtricitabine 200 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 61958-1101 | 61958-1101-01 | — |
| Caystonaztreonam | — | Kit | 61958-0901 | 61958-0901-01 | — |
| Letairisambrisentan | Ambrisentan 5 mg/1 | Tablet, Film coatedOral | 61958-0801 | 61958-0801-0161958-0801-0261958-0801-03+3 more | — |
| Letairisambrisentan | Ambrisentan 10 mg/1 | Tablet, Film coatedOral | 61958-0802 | 61958-0802-0161958-0802-0261958-0802-03+1 more | — |
| Emtrivaemtricitabine | Emtricitabine 10 mg/mL | SolutionOral | 61958-0602 | 61958-0602-01 | — |
| Truvadaemtricitabine and tenofovir disoproxil fumarate | Emtricitabine 200 mg/1; Tenofovir disoproxil fumarate 300 mg/1 | Tablet, Film coatedOral | 61958-0701 | 61958-0701-01 | — |
| Emtrivaemtricitabine | Emtricitabine 200 mg/1 | CapsuleOral | 61958-0601 | 61958-0601-01 | — |
| Vireadtenofovir disoproxil fumarate | Tenofovir disoproxil fumarate 300 mg/1 | Tablet, CoatedOral | 61958-0401 | 61958-0401-01 | — |
Gilead Sciences, Inc.: common questions
- What is Gilead Sciences, Inc.'s NDC labeler code?
- 55135, 61958. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Gilead Sciences, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.